{"id":62517,"date":"2025-04-10T16:45:46","date_gmt":"2025-04-10T19:45:46","guid":{"rendered":"https:\/\/idor.clientes.lojainterativa.com\/?p=62517"},"modified":"2025-04-11T12:20:23","modified_gmt":"2025-04-11T15:20:23","slug":"idor-participa-do-x-congresso-internacional-oncologia-dor","status":"publish","type":"post","link":"https:\/\/www.rededorsaoluiz.com.br\/instituto\/idor\/idor-participa-do-x-congresso-internacional-oncologia-dor\/","title":{"rendered":"IDOR participa do X Congresso Internacional Oncologia D\u2019Or"},"content":{"rendered":"<div class=\"wpb-content-wrapper\"><p>[vc_row][vc_column width=&#8221;1\/2&#8243;][vc_column_text css=&#8221;&#8221;]<span data-contrast=\"auto\">Nos dias 4 e 5 de abril, o Rio de Janeiro foi palco do X Congresso Internacional Oncologia D\u2019Or \u2013 Onco in Rio, o maior evento cient\u00edfico da Rede D\u2019Or.<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559740&quot;:257}\">&nbsp;<\/span><\/p>\n<p><span data-contrast=\"auto\">A d\u00e9cima edi\u00e7\u00e3o trouxe n\u00fameros ainda maiores para o evento: <\/span>&nbsp;<\/p>\n<ul>\n<li><span data-contrast=\"auto\">120 horas de programa\u00e7\u00e3o cient\u00edfica; <\/span>&nbsp;<\/li>\n<li><span data-contrast=\"auto\">9 palestrantes internacionais;<\/span><\/li>\n<li><span data-contrast=\"auto\">326 palestrantes nacionais;<\/span><\/li>\n<li><span data-contrast=\"auto\">3.600 participantes.<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559740&quot;:257}\">&nbsp;<\/span><\/li>\n<\/ul>\n<p><span data-contrast=\"auto\">Os congressistas puderam usufruir das apresenta\u00e7\u00f5es, mesas-redondas e debates nas 9 salas de programa\u00e7\u00e3o distribu\u00eddas em 21 m\u00f3dulos.&nbsp;<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559740&quot;:257}\">&nbsp;<\/span><\/p>\n<p><span class=\"TextRun SCXW13951679 BCX0\" lang=\"PT-BR\" xml:lang=\"PT-BR\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW13951679 BCX0\">A cerim\u00f4nia de abertura do evento contou com a participa\u00e7\u00e3o do <\/span><\/span><strong><span class=\"TextRun SCXW13951679 BCX0\" lang=\"PT-BR\" xml:lang=\"PT-BR\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW13951679 BCX0\">Dr. Jorge Moll Filho<\/span><\/span><\/strong><span class=\"TextRun SCXW13951679 BCX0\" lang=\"PT-BR\" xml:lang=\"PT-BR\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW13951679 BCX0\">, <\/span><\/span><span class=\"TextRun SCXW13951679 BCX0\" lang=\"PT-BR\" xml:lang=\"PT-BR\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW13951679 BCX0\">chairman<\/span><\/span><span class=\"TextRun SCXW13951679 BCX0\" lang=\"PT-BR\" xml:lang=\"PT-BR\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW13951679 BCX0\"> da Rede D\u2019Or, <\/span><\/span><strong><span class=\"TextRun SCXW13951679 BCX0\" lang=\"PT-BR\" xml:lang=\"PT-BR\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW13951679 BCX0\">Prof. <\/span><span class=\"NormalTextRun SCXW13951679 BCX0\">Dr. Paulo M. Hoff<\/span><\/span><\/strong><span class=\"TextRun SCXW13951679 BCX0\" lang=\"PT-BR\" xml:lang=\"PT-BR\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW13951679 BCX0\">, presidente da Oncologia D<\/span><span class=\"NormalTextRun SCXW13951679 BCX0\">\u2019Or e do Congresso, <\/span><\/span><strong><span class=\"TextRun SCXW13951679 BCX0\" lang=\"PT-BR\" xml:lang=\"PT-BR\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW13951679 BCX0\">Dra. Fernanda Tovar-Moll<\/span><\/span><\/strong><span class=\"TextRun SCXW13951679 BCX0\" lang=\"PT-BR\" xml:lang=\"PT-BR\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW13951679 BCX0\">, presidente do IDOR, <\/span><\/span><strong><span class=\"TextRun SCXW13951679 BCX0\" lang=\"PT-BR\" xml:lang=\"PT-BR\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW13951679 BCX0\">Dr. Leandro Reis<\/span><\/span><\/strong><span class=\"TextRun SCXW13951679 BCX0\" lang=\"PT-BR\" xml:lang=\"PT-BR\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW13951679 BCX0\">, Vice-presidente da Rede D\u2019Or, <\/span><\/span><strong><span class=\"TextRun SCXW13951679 BCX0\" lang=\"PT-BR\" xml:lang=\"PT-BR\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW13951679 BCX0\">Rodrigo Gavina<\/span><\/span><\/strong><span class=\"TextRun SCXW13951679 BCX0\" lang=\"PT-BR\" xml:lang=\"PT-BR\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW13951679 BCX0\">, CEO da Oncologia D\u2019Or.<\/span><\/span><span class=\"EOP SCXW13951679 BCX0\" data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559740&quot;:257}\">&nbsp;<\/span>[\/vc_column_text][\/vc_column][vc_column width=&#8221;1\/2&#8243;][vc_gallery interval=&#8221;3&#8243; images=&#8221;62621,62623,62679,62678&#8243; img_size=&#8221;full&#8221; css=&#8221;&#8221;][\/vc_column][\/vc_row][vc_row][vc_column width=&#8221;1\/2&#8243;][vc_column_text css=&#8221;&#8221;]<strong><span class=\"TextRun SCXW206464471 BCX0\" lang=\"PT-BR\" xml:lang=\"PT-BR\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW206464471 BCX0\">Dr. David Uip<\/span><\/span><\/strong><span class=\"TextRun SCXW206464471 BCX0\" lang=\"PT-BR\" xml:lang=\"PT-BR\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW206464471 BCX0\">, coordenador nacional da infectologia da Rede D\u2019Or<\/span><span class=\"NormalTextRun SCXW206464471 BCX0\">,<\/span><span class=\"NormalTextRun SCXW206464471 BCX0\"> co<\/span><span class=\"NormalTextRun SCXW206464471 BCX0\">mand<\/span><span class=\"NormalTextRun SCXW206464471 BCX0\">ou um m\u00f3dulo dedicado \u00e0 \u00e1rea<\/span><span class=\"NormalTextRun SCXW206464471 BCX0\">, abordando temas<\/span><span class=\"NormalTextRun SCXW206464471 BCX0\"> relacionados ao gerenciamento<\/span><span class=\"NormalTextRun SCXW206464471 BCX0\"> de antimicrobianos em pacientes oncol\u00f3gicos<\/span><span class=\"NormalTextRun SCXW206464471 BCX0\">. <\/span><span class=\"NormalTextRun SCXW206464471 BCX0\">O IDOR foi representado pelos seguintes pesquisadores<\/span><span class=\"NormalTextRun SCXW206464471 BCX0\">:<\/span> <\/span><strong><span class=\"TextRun SCXW206464471 BCX0\" lang=\"PT-BR\" xml:lang=\"PT-BR\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW206464471 BCX0\">Dr. Daniel Ferraz<\/span><\/span><\/strong><span class=\"TextRun SCXW206464471 BCX0\" lang=\"PT-BR\" xml:lang=\"PT-BR\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW206464471 BCX0\">, pesquisador do IDOR e <\/span><\/span><span class=\"TextRun SCXW206464471 BCX0\" lang=\"PT-BR\" xml:lang=\"PT-BR\" data-contrast=\"auto\"><span class=\"NormalTextRun SpellingErrorV2Themed SCXW206464471 BCX0\">head<\/span> <\/span><span class=\"TextRun SCXW206464471 BCX0\" lang=\"PT-BR\" xml:lang=\"PT-BR\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW206464471 BCX0\">de intelig\u00eancia artificial da Rede D\u2019<\/span><span class=\"NormalTextRun SCXW206464471 BCX0\">Or, comentando sobre o<\/span><span class=\"NormalTextRun SCXW206464471 BCX0\"> uso de IA para antecipar uma prov\u00e1vel resist\u00eancia<\/span><span class=\"NormalTextRun SCXW206464471 BCX0\"> bacteriana<\/span><span class=\"NormalTextRun SCXW206464471 BCX0\">; <\/span><\/span><strong><span class=\"TextRun SCXW206464471 BCX0\" lang=\"PT-BR\" xml:lang=\"PT-BR\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW206464471 BCX0\">Dr. Daniel Wagner Santos<\/span><\/span><\/strong><span class=\"TextRun SCXW206464471 BCX0\" lang=\"PT-BR\" xml:lang=\"PT-BR\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW206464471 BCX0\">, pesquisador do IDOR<\/span><span class=\"NormalTextRun SCXW206464471 BCX0\">, <\/span><span class=\"NormalTextRun SCXW206464471 BCX0\">falando sobre a antibioticoterapia das infec\u00e7\u00f5es urin\u00e1rias,<\/span><span class=\"NormalTextRun SCXW206464471 BCX0\"> e ainda, o <\/span><\/span><strong><span class=\"TextRun SCXW206464471 BCX0\" lang=\"PT-BR\" xml:lang=\"PT-BR\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW206464471 BCX0\">Dr. Pedro Peloso<\/span><\/span><\/strong><span class=\"TextRun SCXW206464471 BCX0\" lang=\"PT-BR\" xml:lang=\"PT-BR\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW206464471 BCX0\">,<\/span><span class=\"NormalTextRun SCXW206464471 BCX0\"> gerente nacional de microbiologia e biologia molecular do <\/span><span class=\"NormalTextRun SpellingErrorV2Themed SCXW206464471 BCX0\">Richet<\/span><span class=\"NormalTextRun SCXW206464471 BCX0\"> e pesquisador do IDOR,<\/span> <span class=\"NormalTextRun SCXW206464471 BCX0\">trazendo casos cl\u00ednicos que utilizaram o Sequenciamento de Nova Gera\u00e7\u00e3o para o<\/span><span class=\"NormalTextRun SCXW206464471 BCX0\"> diagn\u00f3stico de doen\u00e7as infecciosas<\/span><span class=\"NormalTextRun SCXW206464471 BCX0\">.<\/span><\/span><span class=\"EOP SCXW206464471 BCX0\" data-ccp-props=\"{}\">&nbsp;<\/span>[\/vc_column_text][\/vc_column][vc_column width=&#8221;1\/2&#8243;][vc_gallery interval=&#8221;3&#8243; images=&#8221;62539,62544,62669&#8243; img_size=&#8221;full&#8221; css=&#8221;&#8221;][\/vc_column][\/vc_row][vc_row][vc_column width=&#8221;1\/3&#8243;][vc_single_image image=&#8221;62627&#8243; img_size=&#8221;full&#8221; css=&#8221;&#8221;][\/vc_column][vc_column width=&#8221;1\/3&#8243;][vc_single_image image=&#8221;62626&#8243; img_size=&#8221;full&#8221; css=&#8221;&#8221;][\/vc_column][vc_column width=&#8221;1\/3&#8243;][vc_single_image image=&#8221;62666&#8243; img_size=&#8221;full&#8221; css=&#8221;&#8221;][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text css=&#8221;&#8221;]<strong><span class=\"TextRun SCXW77752833 BCX0\" lang=\"PT-BR\" xml:lang=\"PT-BR\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW77752833 BCX0\">Dr. Fernando Soares<\/span><\/span><\/strong><span class=\"TextRun SCXW77752833 BCX0\" lang=\"PT-BR\" xml:lang=\"PT-BR\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW77752833 BCX0\"> e <\/span><\/span><span class=\"TextRun SCXW77752833 BCX0\" lang=\"PT-BR\" xml:lang=\"PT-BR\" data-contrast=\"auto\"><strong><span class=\"NormalTextRun SCXW77752833 BCX0\">Dra. Isabela Werneck<\/span><\/strong><span class=\"NormalTextRun SCXW77752833 BCX0\">,<\/span><\/span><span class=\"TextRun SCXW77752833 BCX0\" lang=\"PT-BR\" xml:lang=\"PT-BR\" data-contrast=\"auto\"> <span class=\"NormalTextRun SCXW77752833 BCX0\">diretor m\u00e9dico <\/span><span class=\"NormalTextRun SCXW77752833 BCX0\">e coordenadora m\u00e9dica <\/span><span class=\"NormalTextRun SCXW77752833 BCX0\">da Anatomia Patol\u00f3gica da Rede D<\/span><span class=\"NormalTextRun SCXW77752833 BCX0\">\u2019<\/span><span class=\"NormalTextRun SCXW77752833 BCX0\">Or<\/span><span class=\"NormalTextRun SCXW77752833 BCX0\">, respectivamente<\/span><span class=\"NormalTextRun SCXW77752833 BCX0\">,<\/span><span class=\"NormalTextRun SCXW77752833 BCX0\"> e pesquisador<\/span><span class=\"NormalTextRun SCXW77752833 BCX0\">es<\/span><span class=\"NormalTextRun SCXW77752833 BCX0\"> do IDOR<\/span><span class=\"NormalTextRun SCXW77752833 BCX0\">,<\/span><span class=\"NormalTextRun SCXW77752833 BCX0\"> foram respons\u00e1veis <\/span><span class=\"NormalTextRun SCXW77752833 BCX0\">pelo<\/span> <span class=\"NormalTextRun SCXW77752833 BCX0\">m\u00f3dulo da patologia<\/span><span class=\"NormalTextRun SCXW77752833 BCX0\">. <\/span><span class=\"NormalTextRun SCXW77752833 BCX0\">Dentre os palestrantes que participaram da discuss\u00e3o<\/span><span class=\"NormalTextRun SCXW77752833 BCX0\"> est\u00e3o <\/span><span class=\"NormalTextRun SCXW77752833 BCX0\">o <\/span><\/span><strong><span class=\"TextRun SCXW77752833 BCX0\" lang=\"PT-BR\" xml:lang=\"PT-BR\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW77752833 BCX0\">Dr. Tiago Machuca<\/span><\/span><\/strong><span class=\"TextRun SCXW77752833 BCX0\" lang=\"PT-BR\" xml:lang=\"PT-BR\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW77752833 BCX0\">, diretor nacional de medicina respirat\u00f3ria de alta complexi<\/span><span class=\"NormalTextRun SCXW77752833 BCX0\">dade da Rede D\u2019Or, apontando os principais avan\u00e7os <\/span><span class=\"NormalTextRun SCXW77752833 BCX0\">do t<\/span><span class=\"NormalTextRun SCXW77752833 BCX0\">ransplante pulmonar em pacientes com carcinoma<\/span><span class=\"NormalTextRun SCXW77752833 BCX0\">, com casos reais realizados no exterior e no Brasil<\/span><span class=\"NormalTextRun SCXW77752833 BCX0\">.<\/span><span class=\"NormalTextRun SCXW77752833 BCX0\"> Tamb\u00e9m particip<\/span><span class=\"NormalTextRun SCXW77752833 BCX0\">ou<\/span><span class=\"NormalTextRun SCXW77752833 BCX0\"> o <\/span><\/span><strong><span class=\"TextRun SCXW77752833 BCX0\" lang=\"PT-BR\" xml:lang=\"PT-BR\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW77752833 BCX0\">Dr. Raymundo Paran\u00e1<\/span><\/span><\/strong><span class=\"TextRun SCXW77752833 BCX0\" lang=\"PT-BR\" xml:lang=\"PT-BR\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW77752833 BCX0\">, pesquisador do IDOR<\/span><span class=\"NormalTextRun SCXW77752833 BCX0\"> e diretor m\u00e9dico do Hospital Alian\u00e7a, <\/span><span class=\"NormalTextRun SCXW77752833 BCX0\">apresentando dados sobre hepatotoxicidade por ervas e compostos fitoter\u00e1picos. \u201cUm t\u00f3pico que precisa ser difundido para denunciar os abusos que adoecem seres humanos\u201d, o hepatologista comentou<\/span><span class=\"NormalTextRun SCXW77752833 BCX0\"> em uma postagem em sua rede social<\/span><span class=\"NormalTextRun SCXW77752833 BCX0\">. <\/span><\/span><strong><span class=\"TextRun SCXW77752833 BCX0\" lang=\"PT-BR\" xml:lang=\"PT-BR\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW77752833 BCX0\">Dra. Mariana <\/span><span class=\"NormalTextRun SpellingErrorV2Themed SCXW77752833 BCX0\">Petac<\/span><span class=\"NormalTextRun SpellingErrorV2Themed SCXW77752833 BCX0\">cia<\/span><\/span><\/strong><span class=\"TextRun SCXW77752833 BCX0\" lang=\"PT-BR\" xml:lang=\"PT-BR\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW77752833 BCX0\">, coo<\/span><span class=\"NormalTextRun SCXW77752833 BCX0\">rdenadora m\u00e9dica da patologia molecular Rede D\u2019<\/span><span class=\"NormalTextRun SpellingErrorV2Themed SCXW77752833 BCX0\">Or<\/span><span class=\"NormalTextRun SCXW77752833 BCX0\">\/ID<\/span><span class=\"NormalTextRun SCXW77752833 BCX0\">OR<\/span><span class=\"NormalTextRun SCXW77752833 BCX0\">, palestrou sobre o sequenciam<\/span><span class=\"NormalTextRun SCXW77752833 BCX0\">ento gen\u00e9tico em oncologia e por fim, <\/span><\/span><span class=\"TextRun SCXW77752833 BCX0\" lang=\"PT-BR\" xml:lang=\"PT-BR\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW77752833 BCX0\">Dr. Fernando Soares<\/span><\/span><span class=\"TextRun SCXW77752833 BCX0\" lang=\"PT-BR\" xml:lang=\"PT-BR\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW77752833 BCX0\"> trouxe coment\u00e1rios pertinentes sobre o futuro dos testes moleculares n<\/span><span class=\"NormalTextRun SCXW77752833 BCX0\">a pr\u00e1tica da oncologia.<\/span><\/span><span class=\"EOP SCXW77752833 BCX0\" data-ccp-props=\"{}\">&nbsp;<\/span>[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column width=&#8221;1\/2&#8243;][vc_single_image image=&#8221;62565&#8243; img_size=&#8221;full&#8221; css=&#8221;&#8221;][vc_column_text css=&#8221;&#8221;]<span class=\"TextRun SCXW85287474 BCX0\" lang=\"PT-BR\" xml:lang=\"PT-BR\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW85287474 BCX0\">Ainda participaram,<\/span> <\/span><strong><span class=\"TextRun SCXW85287474 BCX0\" lang=\"PT-BR\" xml:lang=\"PT-BR\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW85287474 BCX0\">Dr. <\/span><span class=\"NormalTextRun SCXW85287474 BCX0\">Eduardo Rego<\/span><\/span><\/strong><span class=\"TextRun SCXW85287474 BCX0\" lang=\"PT-BR\" xml:lang=\"PT-BR\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW85287474 BCX0\">, <\/span><span class=\"NormalTextRun SCXW85287474 BCX0\">coordenador nacional da hematologia da Oncologia D\u2019Or e pesquisador do IDOR, que foi moderador e palestrante de uma sess\u00e3o que abordou sobre leucemias aguda<\/span><span class=\"NormalTextRun SCXW85287474 BCX0\">s. <\/span><span class=\"NormalTextRun SCXW85287474 BCX0\">\u201cMomentos como esse refor\u00e7am a import\u00e2ncia da colabora\u00e7\u00e3o cient\u00edfica, da escuta qualificada e do compartilhamento de experi\u00eancias entre profissionais que atuam com excel\u00eancia e prop\u00f3sito\u201d <\/span><span class=\"NormalTextRun SCXW85287474 BCX0\">comentou <\/span><span class=\"NormalTextRun SCXW85287474 BCX0\">em sua rede social.<\/span><\/span>[\/vc_column_text][\/vc_column][vc_column width=&#8221;1\/2&#8243;][vc_single_image image=&#8221;62667&#8243; img_size=&#8221;full&#8221; css=&#8221;&#8221;][vc_column_text css=&#8221;&#8221;]<strong><span class=\"TextRun SCXW85287474 BCX0\" lang=\"PT-BR\" xml:lang=\"PT-BR\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW85287474 BCX0\">Dr. Vanderson Rocha<\/span><\/span><\/strong><span class=\"TextRun SCXW85287474 BCX0\" lang=\"PT-BR\" xml:lang=\"PT-BR\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW85287474 BCX0\">, coordenador nacional de terapia celular na Rede D\u2019Or e pesquisador no IDOR, palestrou em dois momentos trazendo <\/span><span class=\"NormalTextRun SCXW85287474 BCX0\">as novidades sobre a terapia celular <\/span><span class=\"NormalTextRun SCXW85287474 BCX0\">e<\/span><span class=\"NormalTextRun SCXW85287474 BCX0\"> discutindo sobre os pacientes de mieloma eleg\u00edveis a<\/span><span class=\"NormalTextRun SCXW85287474 BCX0\"> esse tipo de<\/span><span class=\"NormalTextRun SCXW85287474 BCX0\"> tratamento.<\/span><\/span>[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text css=&#8221;&#8221;]<strong><span class=\"TextRun SCXW85287474 BCX0\" lang=\"PT-BR\" xml:lang=\"PT-BR\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW85287474 BCX0\">Dra. Clarissa <\/span><span class=\"NormalTextRun SpellingErrorV2Themed SCXW85287474 BCX0\">Baldotto<\/span><\/span><\/strong><span class=\"TextRun SCXW85287474 BCX0\" lang=\"PT-BR\" xml:lang=\"PT-BR\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW85287474 BCX0\">, pesquisadora do IDOR, participou de diversas mesas como coordenadora e debated<\/span><span class=\"NormalTextRun SCXW85287474 BCX0\">ora. <strong><span class=\"TextRun SCXW114640401 BCX0\" lang=\"PT-BR\" xml:lang=\"PT-BR\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW114640401 BCX0\">Dra. Laura Testa<\/span><\/span><\/strong><span class=\"TextRun SCXW114640401 BCX0\" lang=\"PT-BR\" xml:lang=\"PT-BR\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW114640401 BCX0\">, <\/span><span class=\"NormalTextRun SCXW114640401 BCX0\">pesquisadora do IDOR, <\/span><span class=\"NormalTextRun SCXW114640401 BCX0\">falou <\/span><span class=\"NormalTextRun SCXW114640401 BCX0\">sobre <\/span><span class=\"NormalTextRun SCXW114640401 BCX0\">a <\/span><span class=\"NormalTextRun SpellingErrorV2Themed SCXW114640401 BCX0\">endocrinoterapia<\/span><span class=\"NormalTextRun SCXW114640401 BCX0\"> em pacientes com c\u00e2ncer de mama.<\/span> <\/span><strong><span class=\"TextRun SCXW114640401 BCX0\" lang=\"PT-BR\" xml:lang=\"PT-BR\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW114640401 BCX0\">Dr. Carlos <\/span><span class=\"NormalTextRun SpellingErrorV2Themed SCXW114640401 BCX0\">Domene<\/span><\/span><\/strong><span class=\"TextRun SCXW114640401 BCX0\" lang=\"PT-BR\" xml:lang=\"PT-BR\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW114640401 BCX0\">, pesquisador e coordenador m\u00e9dico do programa de cirurgia rob\u00f3tica IDOR\/Rede D\u2019Or, <\/span><span class=\"NormalTextRun SCXW114640401 BCX0\">abordou o t\u00f3pico sobre as aplica\u00e7\u00f5es da<\/span> <span class=\"NormalTextRun SCXW114640401 BCX0\">intelig\u00eancia artificial na cirurgia oncol\u00f3gica<\/span><span class=\"NormalTextRun SCXW114640401 BCX0\">.<\/span> <\/span><strong><span class=\"TextRun SCXW114640401 BCX0\" lang=\"PT-BR\" xml:lang=\"PT-BR\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW114640401 BCX0\">Dr. Thiago Romano<\/span><\/span><\/strong><span class=\"TextRun SCXW114640401 BCX0\" lang=\"PT-BR\" xml:lang=\"PT-BR\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW114640401 BCX0\">,<\/span><span class=\"NormalTextRun SCXW114640401 BCX0\"> coordenador m\u00e9dico da UTI oncol\u00f3gica na Rede D\u2019Or e <\/span><span class=\"NormalTextRun SCXW114640401 BCX0\">coordenador da p\u00f3s-gradua\u00e7\u00e3o de terapia intensiva do IDOR,<\/span> <span class=\"NormalTextRun SCXW114640401 BCX0\">lider<\/span><span class=\"NormalTextRun SCXW114640401 BCX0\">ou o m\u00f3dulo de terapia intensiva em oncologia do qual abordou t\u00f3picos como <\/span><span class=\"NormalTextRun SCXW114640401 BCX0\">infec\u00e7\u00f5es oportunistas em pacientes imunocomprometidos<\/span><span class=\"NormalTextRun SCXW114640401 BCX0\"> e<\/span><span class=\"NormalTextRun SCXW114640401 BCX0\"> cuidados de alto valor em <\/span><span class=\"NormalTextRun SpellingErrorV2Themed SCXW114640401 BCX0\">oncointensivismo<\/span><span class=\"NormalTextRun SCXW114640401 BCX0\">.<\/span><\/span><span class=\"EOP SCXW114640401 BCX0\" data-ccp-props=\"{}\">&nbsp;<\/span><\/span><\/span><\/p>\n<p><span data-contrast=\"auto\">Os residentes IDOR\/Rede D\u2019Or tamb\u00e9m tiveram uma sess\u00e3o dedicada durante o Congresso. Durante o m\u00f3dulo Avan\u00e7os da Cirurgia, residentes egressos de Oncologia Cl\u00ednica do IDOR RJ e SP, al\u00e9m do residente de Cirurgia Tor\u00e1cica do IDOR RJ, falaram sobre os diferenciais e as oportunidades vivenciadas durante os Programas de Resid\u00eancia. \u201cCompartilhar experi\u00eancias com outros futuros residentes e estagi\u00e1rios de medicina tamb\u00e9m promove uma reflex\u00e3o sobre esta trajet\u00f3ria t\u00e3o importante na vida de um m\u00e9dico\u201d destaca <\/span><b><span data-contrast=\"auto\">Dra. Alessandra Thompson<\/span><\/b><span data-contrast=\"auto\">, coordenadora da COREME Nacional.<\/span><span data-ccp-props=\"{}\">&nbsp;<\/span><\/p>\n<p><span data-contrast=\"auto\">Falando sobre o cuidado multidisciplinar, contamos com uma apresenta\u00e7\u00e3o da <\/span><b><span data-contrast=\"auto\">Dra. Helidea Lima<\/span><\/b><span data-contrast=\"auto\">, diretora da qualidade assistencial da Rede D\u2019Or e coordenadora dos cursos de MBA do IDOR, relatando sobre a import\u00e2ncia do engajamento da equipe no impacto da experi\u00eancia do paciente.<\/span><span data-ccp-props=\"{}\">&nbsp;<\/span>[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column width=&#8221;1\/2&#8243;][vc_column_text css=&#8221;&#8221;]<span data-contrast=\"auto\">Como entidade de apoio no evento, respons\u00e1vel pela capta\u00e7\u00e3o financeira, relacionamento e organiza\u00e7\u00e3o da programa\u00e7\u00e3o, o IDOR contou um stand em parceria com a Anatomia Patol\u00f3gica. L\u00e1 os visitantes puderam tirar d\u00favidas com nossos profissionais e conhecer mais sobre o instituto e suas \u00e1reas de pesquisa e ensino.<\/span><span data-ccp-props=\"{}\">&nbsp;<\/span><\/p>\n<p><span data-contrast=\"auto\">Ainda tivemos um espa\u00e7o dedicado na agenda: o m\u00f3dulo de Pesquisa IDOR, realizado no dia 5 de abril. Sob coordena\u00e7\u00e3o da presidente do IDOR, <\/span><b><span data-contrast=\"auto\">Dra. Fernanda Tovar-Moll<\/span><\/b><span data-contrast=\"auto\"> e do diretor de pesquisa e inova\u00e7\u00e3o, <\/span><b><span data-contrast=\"auto\">Dr. Luiz Eug\u00eanio Mello<\/span><\/b><span data-contrast=\"auto\">, o m\u00f3dulo tamb\u00e9m teve a participa\u00e7\u00e3o do palestrante internacional, <\/span><b><span data-contrast=\"auto\">Eric Walk<\/span><\/b><span data-contrast=\"auto\">, diretor m\u00e9dico na PathAI em Boston (EUA).<\/span><span data-ccp-props=\"{}\">&nbsp;<\/span>[\/vc_column_text][\/vc_column][vc_column width=&#8221;1\/2&#8243;][vc_gallery interval=&#8221;3&#8243; images=&#8221;62561,62682,62681,62563,62631&#8243; img_size=&#8221;full&#8221; css=&#8221;&#8221;][\/vc_column][\/vc_row][vc_row][vc_column width=&#8221;1\/2&#8243;][vc_single_image image=&#8221;62560&#8243; img_size=&#8221;full&#8221; css=&#8221;&#8221;][vc_single_image image=&#8221;62559&#8243; img_size=&#8221;full&#8221; css=&#8221;&#8221;][\/vc_column][vc_column width=&#8221;1\/2&#8243;][vc_column_text css=&#8221;&#8221;]<span data-contrast=\"auto\">Como grande destaque, o <\/span><b><span data-contrast=\"auto\">Dr. Rodrigo Guindalini<\/span><\/b><span data-contrast=\"auto\"> apresentou o projeto ORIGEM \u2013 iniciativa apoiada pelo IDOR que busca desenvolver escores de risco polig\u00eanicos em pacientes com c\u00e2ncer de c\u00f3lon atrav\u00e9s do estudo da ancestralidade e da diversidade em mapas gen\u00e9ticos de popula\u00e7\u00e3o brasileira.&nbsp;<\/span><span data-ccp-props=\"{}\">&nbsp;<\/span><\/p>\n<p><span data-contrast=\"auto\">O estudo deve percorrer um longo caminho at\u00e9 ter os primeiros resultados \u2013 neste momento, a equipe liderada pelo Dr. Rodrigo e pela <\/span><b><span data-contrast=\"auto\">Dra. Camila Venchiarutti<\/span><\/b><span data-contrast=\"auto\">, gerente m\u00e9dica de pesquisa cl\u00ednica do IDOR, est\u00e1 na fase de coleta dos casos, esfor\u00e7o poss\u00edvel gra\u00e7as a vasta estrutura de atendimento da Rede.<\/span><span data-ccp-props=\"{}\">&nbsp;<\/span><\/p>\n<p><span data-contrast=\"auto\">Dado a nossa composi\u00e7\u00e3o gen\u00e9tica miscigenada, estudos que visam o desenvolvimento de escores de risco n\u00e3o costumam se aplicar a realidade brasileira. O projeto ORIGEM criar\u00e1 esse mapa, permitindo o diagn\u00f3stico precoce e a predi\u00e7\u00e3o de futuros casos de c\u00e2ncer de c\u00f3lon &#8211; uma das neoplasias mais agressivas da atualidade e que tem afetado especialmente camadas mais jovens da popula\u00e7\u00e3o.<\/span>[\/vc_column_text][vc_column_text css=&#8221;&#8221;]<span data-contrast=\"auto\">\u201cAs apresenta\u00e7\u00f5es do Dr. Rodrigo Guindalini e <\/span><b><span data-contrast=\"auto\">Dr. Eric Walk<\/span><\/b><span data-contrast=\"auto\"> ilustraram as contribui\u00e7\u00f5es de projetos de pesquisa relevantes cientificamente e apontam para o futuro da medicina. A oncologia \u00e9, dentre as especialidades m\u00e9dicas, uma das que mais tem avan\u00e7ado. Se hoje falamos em cura para alguns tipos de c\u00e2ncer, isso vem se dando gra\u00e7a a esse tipo de intera\u00e7\u00e3o, como o que ocorre entre a Rede D\u2019Or, Oncologia D\u2019Or e o IDOR\u201d declarou <strong>Dr. Luiz Eug\u00eanio Mello<\/strong>.<\/span><span data-ccp-props=\"{}\">&nbsp;<\/span>[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text css=&#8221;&#8221;]<span data-contrast=\"auto\">Para o encerramento do Congresso, tivemos a participa\u00e7\u00e3o do <\/span><b><span data-contrast=\"auto\">Prof. Dr. Paulo M. Hoff<\/span><\/b><span data-contrast=\"auto\"> e <\/span><b><span data-contrast=\"auto\">Dr. Paulo Moll<\/span><\/b><span data-contrast=\"auto\">, CEO da Rede D\u2019Or, em um bate papo sobre os desafios da sa\u00fade no pa\u00eds, as perspectivas de mercado e o futuro da Rede.<\/span><span data-ccp-props=\"{}\">&nbsp;<\/span><\/p>\n<p><span data-contrast=\"auto\">Participar da organiza\u00e7\u00e3o desse evento e contribuir com palestras ricos em conte\u00fado inovador faz parte da nossa miss\u00e3o de inspirar e transformar por meio da ci\u00eancia e da educa\u00e7\u00e3o em sa\u00fade.&nbsp;<\/span><span data-ccp-props=\"{}\">&nbsp;<\/span><\/p>\n<p><span data-contrast=\"auto\">Escrito por Manuelly Gomes e Caio Pomin<br \/>\nRevis\u00e3o por Claudio Ferrari<br \/>\nFotos: Comunica\u00e7\u00e3o &amp; Marketing IDOR e CCM<\/span>[\/vc_column_text][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>Como entidade de apoio no evento, respons\u00e1vel pela capta\u00e7\u00e3o financeira, relacionamento e organiza\u00e7\u00e3o da programa\u00e7\u00e3o, o IDOR contou um stand em parceria com a Anatomia Patol\u00f3gica. L\u00e1 os visitantes puderam tirar d\u00favidas com nossos profissionais e conhecer mais sobre o instituto e suas \u00e1reas de pesquisa e ensino. <\/p>\n","protected":false},"author":4,"featured_media":62563,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"ngg_post_thumbnail":0,"_joinchat":[],"footnotes":""},"categories":[3,11,61,62],"tags":[],"class_list":["post-62517","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-event","category-research","category-novidades","category-ensino"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.rededorsaoluiz.com.br\/instituto\/idor\/wp-json\/wp\/v2\/posts\/62517","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.rededorsaoluiz.com.br\/instituto\/idor\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.rededorsaoluiz.com.br\/instituto\/idor\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.rededorsaoluiz.com.br\/instituto\/idor\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.rededorsaoluiz.com.br\/instituto\/idor\/wp-json\/wp\/v2\/comments?post=62517"}],"version-history":[{"count":9,"href":"https:\/\/www.rededorsaoluiz.com.br\/instituto\/idor\/wp-json\/wp\/v2\/posts\/62517\/revisions"}],"predecessor-version":[{"id":62683,"href":"https:\/\/www.rededorsaoluiz.com.br\/instituto\/idor\/wp-json\/wp\/v2\/posts\/62517\/revisions\/62683"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.rededorsaoluiz.com.br\/instituto\/idor\/wp-json\/wp\/v2\/media\/62563"}],"wp:attachment":[{"href":"https:\/\/www.rededorsaoluiz.com.br\/instituto\/idor\/wp-json\/wp\/v2\/media?parent=62517"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.rededorsaoluiz.com.br\/instituto\/idor\/wp-json\/wp\/v2\/categories?post=62517"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.rededorsaoluiz.com.br\/instituto\/idor\/wp-json\/wp\/v2\/tags?post=62517"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}